The genetic expression LGI3 (Leucine rich repeat LGI family member 3) among different NSLC cell lines and its effect on proliferation of cancer cells

J. Shin (Seoul, Republic of Korea), I. Park (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), H. Yun (Seoul, Republic of Korea)

Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Session: Molecular alterations and immunology in lung cancer
Session type: E-poster session
Number: 1654
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Shin (Seoul, Republic of Korea), I. Park (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), H. Yun (Seoul, Republic of Korea). The genetic expression LGI3 (Leucine rich repeat LGI family member 3) among different NSLC cell lines and its effect on proliferation of cancer cells. 1654

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Overexpression of inhibitor of DNA-binding proteins and angiogenic markers have higher impact on survival of non small cell lung cancer patients
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012


Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004

Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system
Source: Eur Respir J 2007; 30: Suppl. 51, 715s
Year: 2007

Targeting gene of insulin-like growth factor type I (IGF-I) on in vitro model of A549 cell line with triple-helix approach. Perspectives of gene therapy in non-small cell lung (NSCLC) cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006

NEUROD1 is highly expressed in extensive disease small cell lung cancer by promoting migration.
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020

Inhibition of B7-H4 gene expression by RNA interference (RNAi) in lung cancer A549 cell line
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011

Expression profiles of inhibitory of growth family member 4 (ING4) in different forms of pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

The influence of conventional and targeted chemotherapy on the expression of stem cell markers in lung cancer cell lines
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017



Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006

Phenotype pattern of human non-small cell lung cancer (NSCLC) model line in immune escape phenomenon. Effect of transfection with plasmids encoding specific anti-EGFR1 and anti-HER2/neu short hairpin (SH)RNA sequences
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009


Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Late-breaking abstract: Relationship of aquaporin 1, 3 and 5 expression in lung cancer cells to cellular differentiation, invasive growth and metastasis potential
Source: Annual Congress 2011 - Treatment of lung cancer
Year: 2011


MiR-34a favours macrophage polarization switch from M2 to M1 phenotype in non small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


The effects of TNF-α combined with VP16 on growth and cell cycle of lung cancer cell line and the adhesive molecules
Source: Eur Respir J 2002; 20: Suppl. 38, 73s
Year: 2002

Investigation of a relationship between NF-KB1A gene polymorphism and non small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012

Overall survival analysis and characterization of an EGFR mutated non small cell lung cancer (NSCLC) population
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


N-terminal deletion augments the cell death-inducing activity of BAX in the adenoviral gene delivery to nonsmall cell lung cancers
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002

Increased proliferation of type 2 alveolar epithelial cells in a pneumonectomy model mice with a deletion of p16ink4a gene.
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018



Association between protein expression of p63 and final cause of death in non small cell lung cancer
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007